Literature DB >> 3302052

Antibiotic therapy, endotoxin concentration in cerebrospinal fluid, and brain edema in experimental Escherichia coli meningitis in rabbits.

M G Täuber, A M Shibl, C J Hackbarth, J W Larrick, M A Sande.   

Abstract

We investigated the effect of cefotaxime and chloramphenicol on endotoxin concentrations in cerebrospinal fluid (CSF) and on the development of brain edema in rabbits with Escherichia coli meningitis. Both antibiotics were similarly effective in reducing bacterial titers. Cefotaxime, but not chloramphenicol, induced a marked increase of endotoxin in CSF, from log10 1.5 +/- 0.8 to log10 2.8 +/- 0.7 ng/ml (P less than .01). This result was associated with an increase in brain water content (405 +/- 12 g of water/100 g of dry weight compared with 389 +/- 8 g in untreated controls; P less than .01), whereas in animals treated with chloramphenicol, brain water content was identical to controls. The cefotaxime-induced increase in endotoxin concentration and brain edema were both neutralized by polymyxin B, which binds to the lipid A moiety of endotoxin, or by a monoclonal antibody to lipid A. These results indicate that treating gram-negative bacillary meningitis with selected antibiotics induces increased endotoxin concentrations in CSF that are associated with brain edema.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3302052     DOI: 10.1093/infdis/156.3.456

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  36 in total

Review 1.  Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"?

Authors:  M T Labro
Journal:  Clin Microbiol Rev       Date:  2000-10       Impact factor: 26.132

Review 2.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis.

Authors:  J H Tureen; M G Täuber; M A Sande
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

4.  Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.

Authors:  Denis Grandgirard; Melchior Burri; Philipp Agyeman; Stephen L Leib
Journal:  Antimicrob Agents Chemother       Date:  2012-05-29       Impact factor: 5.191

5.  Experimental pneumococcal meningitis causes central nervous system pathology without inducing the 72-kd heat shock protein.

Authors:  M G Täuber; S L Kennedy; J H Tureen; D H Lowenstein
Journal:  Am J Pathol       Date:  1992-07       Impact factor: 4.307

6.  Antibiotic-induced release of endotoxin in chronically bacteriuric patients.

Authors:  J C Hurley; W J Louis; F A Tosolini; J B Carlin
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 7.  Dexamethasone in bacterial meningitis.

Authors:  S K Kabra; P Kumar; I C Verma
Journal:  Indian J Pediatr       Date:  1991 Jul-Aug       Impact factor: 1.967

8.  Haemophilus influenzae lipopolysaccharide-induced blood brain barrier permeability during experimental meningitis in the rat.

Authors:  B Wispelwey; A J Lesse; E J Hansen; W M Scheld
Journal:  J Clin Invest       Date:  1988-10       Impact factor: 14.808

9.  Moxifloxacin in the therapy of experimental pneumococcal meningitis.

Authors:  H Schmidt; A Dalhoff; K Stuertz; F Trostdorf; V Chen; O Schneider; C Kohlsdorfer; W Brück; R Nau
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

10.  A structure-activity relationship for induction of meningeal inflammation by muramyl peptides.

Authors:  M Burroughs; E Rozdzinski; S Geelen; E Tuomanen
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.